Stay updated on p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.
Latest updates to the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedDifference1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference2%
- Check15 days agoChange DetectedDifference2%
- Check22 days agoChange DetectedThe web page has undergone significant updates, including the introduction of a new version (v2.15.0) and a revised description of the study involving the combination of adenoviral p53 (Ad-p53) with immune checkpoint inhibitors, which now emphasizes the intratumoral administration method.SummaryDifference46%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference1%
- Check37 days agoChange DetectedThe page has removed references to Esophageal Cancer and added information about Stomach Cancer.SummaryDifference0.8%
Stay in the know with updates to p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.